AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
UnitedHealth
UNH
|
+$419M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$345M |
| 3 |
Meta Platforms (Facebook)
META
|
+$329M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$326M |
| 5 |
Microsoft
MSFT
|
+$320M |
Top Sells
| 1 |
Apple
AAPL
|
+$264M |
| 2 |
Medtronic
MDT
|
+$255M |
| 3 |
T-Mobile US
TMUS
|
+$221M |
| 4 |
CELG
Celgene Corp
CELG
|
+$198M |
| 5 |
Xerox
XRX
|
+$185M |
Sector Composition
| 1 | Technology | 16.93% |
| 2 | Financials | 15.62% |
| 3 | Healthcare | 14.76% |
| 4 | Consumer Discretionary | 11.29% |
| 5 | Industrials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
CorVel
CRVL
$4.48B
| $1.89M | ﹤0.01% |
65,172
+15,000
| +30% | +$435K |
|
2002
CytomX Therapeutics
CTMX
$355M
| $1.89M | ﹤0.01% |
167,987
| – | – |
|
2003
Stratasys
SSYS
$843M
| $1.88M | ﹤0.01% |
64,000
| – | – |
|
|
SLCA
2004
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.88M | ﹤0.01% |
146,600
+27,674
| +23% | +$354K |
|
|
CRCM
2005
DELISTED
CARE.COM, INC.
CRCM
| $1.87M | ﹤0.01% |
170,636
+44,328
| +35% | +$487K |
|
2006
Frontdoor
FTDR
$4.72B
| $1.87M | ﹤0.01% |
43,019
+2,029
| +5% | +$88.3K |
|
2007
Openlane
KAR
$3.14B
| $1.87M | ﹤0.01% |
74,804
-123,436
| -62% | -$3.09M |
|
2008
Southside Bancshares
SBSI
$918M
| $1.87M | ﹤0.01% |
57,758
+13,900
| +32% | +$450K |
|
2009
Apellis Pharmaceuticals
APLS
$3.28B
| $1.87M | ﹤0.01% |
73,700
+25,700
| +54% | +$651K |
|
2010
Upbound Group
UPBD
$1.46B
| $1.87M | ﹤0.01% |
70,093
+17,660
| +34% | +$470K |
|
|
PBBI
2011
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
| $1.87M | ﹤0.01% |
157,530
+75,297
| +92% | +$892K |
|
2012
Abercrombie & Fitch
ANF
$4.51B
| $1.86M | ﹤0.01% |
116,040
+26,425
| +29% | +$424K |
|
|
WW
2013
DELISTED
WW International
WW
| $1.86M | ﹤0.01% |
97,299
-25,490
| -21% | -$487K |
|
2014
Alerian MLP ETF
AMLP
$10.4B
| $1.84M | ﹤0.01% |
37,427
-1,755
| -4% | -$86.4K |
|
|
MITT
2015
AG Mortgage Investment Trust
MITT
$246M
| $1.84M | ﹤0.01% |
38,633
+1,400
| +4% | +$66.8K |
|
2016
First Busey Corp
BUSE
$2.2B
| $1.84M | ﹤0.01% |
69,723
+12,000
| +21% | +$317K |
|
2017
Origin Bancorp
OBK
$1.12B
| $1.84M | ﹤0.01% |
55,752
+8,000
| +17% | +$264K |
|
2018
JELD-WEN Holding
JELD
$553M
| $1.84M | ﹤0.01% |
86,444
-3,470
| -4% | -$73.7K |
|
2019
Clearway Energy Class C
CWEN
$3.4B
| $1.83M | ﹤0.01% |
108,752
+19,100
| +21% | +$322K |
|
2020
Brookdale Senior Living
BKD
$1.78B
| $1.83M | ﹤0.01% |
253,550
| – | – |
|
|
TRHC
2021
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.83M | ﹤0.01% |
36,600
+12,200
| +50% | +$609K |
|
2022
Ambarella
AMBA
$3.59B
| $1.82M | ﹤0.01% |
41,300
-49,270
| -54% | -$2.17M |
|
2023
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.23B
| $1.82M | ﹤0.01% |
32,120
+1,160
| +4% | +$65.6K |
|
2024
Interparfums
IPAR
$3.48B
| $1.81M | ﹤0.01% |
27,227
+7,000
| +35% | +$465K |
|
2025
STAAR Surgical
STAA
$1.38B
| $1.81M | ﹤0.01% |
61,600
| – | – |
|